InMed Pharmaceuticals Inc.
- INM
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Cannabinoid Therapeutics
- Clinical-stage Pharma
$1.32
Today −0.75%Quote Oct 16, 2026, 08:00 PM UTC
−5.04%over the last month
Max drawdown −6.4%From 1-month high −5.7%3 months −13.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$7.3M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.31
0.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about INMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug Manufacturers - Specialty & Generic
Employees
6